Vasuk Gautam | Bioinformatics | Best Researcher Award

Published on by Technology Scientists

Dr. Vasuk Gautam | Bioinformatics | Best Researcher Award

Sr.Scientist | Norton Research Institute | United States

Dr. Vasuk Gautam is an emerging researcher whose work spans metabolomics, biomarker discovery, and computational methods for enhancing analytical confidence in high-throughput biological studies. With a record of 24 peer-reviewed publications, 13 h-index and over 3,102 citations, Gautam has established a strong early-career footprint marked by methodological innovation and extensive interdisciplinary collaboration. His contributions focus particularly on developing frameworks for improving metabolite identification accuracy—an essential challenge in metabolomics that directly influences the reliability of biomedical and environmental research. Notably, his recent work introducing the concept of “Identification Probability” provides a transferable, automated metric for evaluating identification confidence, positioning it as a potentially transformative tool for large-scale metabolomic pipelines. In parallel, Gautam has contributed significantly to the development of MarkerDB 2.0, a comprehensive biomarker database that integrates molecular, clinical, and contextual information to support precision medicine, translational research, and global health initiatives. His scholarship reflects a blend of computational rigor, domain expertise, and a commitment to open-access scientific resources. Gautam’s collaborations include partnerships with over 180 co-authors, underscoring his active engagement with diverse research groups and his ability to contribute meaningfully to multi-institutional projects. This collaborative network spans biochemistry, bioinformatics, systems biology, and clinical sciences, highlighting the broad applicability and relevance of his expertise. Through both his methodological contributions and his involvement in global data-resource efforts, Gautam’s work supports reproducibility, accessibility, and evidence-based discovery in molecular life sciences. His growing citation impact and participation in influential open-access initiatives demonstrate both scientific merit and societal relevance, particularly in areas related to disease diagnostics, personalized healthcare, and data-driven research infrastructures.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

1. Wishart, D. S., Guo, A. C., Oler, E., Wang, F., Anjum, A., Peters, H., Dizon, R., … (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622–D631.

Cited by: 2116

2. Knox, C., Wilson, M., Klinger, C. M., Franklin, M., Oler, E., Wilson, A., Pon, A., Cox, J., … (2024). DrugBank 6.0: The DrugBank knowledgebase for 2024. Nucleic Acids Research, 52(D1), D1265–D1275.

Cited by: 1112

3. Wishart, D. S., Han, S., Saha, S., Oler, E., Peters, H., Grant, J. R., Stothard, P., … (2023). PHASTEST: Faster than PHASTER, better than PHAST. Nucleic Acids Research, 51(W1), W443–W450.

Cited by: 394

4. Wishart, D. S., Tian, S., Allen, D., Oler, E., Peters, H., Lui, V. W., Gautam, V., … (2022). BioTransformer 3.0: A web server for accurately predicting metabolic transformation products. Nucleic Acids Research, 50(W1), W115–W123.

Cited by: 160

5. Wang, F., Allen, D., Tian, S., Oler, E., Gautam, V., Greiner, R., Metz, T. O., … (2022). CFM-ID 4.0: A web server for accurate MS-based metabolite identification. Nucleic Acids Research, 50(W1), W165–W174.

Cited by: 115

Dr. Vasuk Gautam’s work advances the reliability and scalability of metabolomic and biomarker research, enabling more accurate diagnostics and deeper biological insight. By developing robust identification metrics and contributing to global data resources, he helps accelerate scientific discovery, support precision medicine, and enhance evidence-based decision-making across research, healthcare, and industry.

Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Published on by Technology Scientists

Dr. Daniel Glossman-Mitnik | Computational Biology | Best Academic Researcher Award

Emeritus Researcher|Center for Research in Advanced Materials | Mexico

Dr. Daniel Glossman-Mitnik is a prominent researcher at the Centro de Investigación en Materiales Avanzados (CIMAV), Chihuahua, Mexico, recognized internationally for his extensive contributions to computational and theoretical chemistry. His work primarily employs Density Functional Theory (DFT) and Conceptual DFT (CDFT) to investigate the structural, electronic, and reactive properties of molecules and materials relevant to nanotechnology, materials science, and bioactive compounds. With a prolific record of 62 peer-reviewed publications, his research has accumulated over 817 citations, achieving an h-index of 19, which reflects the sustained impact and academic quality of his scientific output. Dr. Glossman-Mitnik’s recent studies encompass a wide spectrum of applications, including the design of triphenylamine-based sensitizers and Cu(I) complexes for dye-sensitized solar cells (DSSCs), as well as computational evaluations of marine natural products and therapeutic peptides for drug discovery. His scholarly endeavors are characterized by interdisciplinary collaboration, having co-authored with more than 120 researchers worldwide, fostering innovation through theoretical–experimental integration. Beyond his methodological expertise, his research has meaningful social and technological implications, contributing to advancements in renewable energy materials, environmentally sustainable chemical design, and computational approaches to pharmacology. By combining rigorous quantum-chemical modeling with practical applications, Dr. Glossman-Mitnik’s work exemplifies how theoretical insights can drive real-world scientific progress. His career reflects a profound commitment to advancing the global understanding of molecular behavior and material performance, positioning him as a leading figure in contemporary computational chemistry.

Profiles: Scopus | Google Scholar

Featured Publications

1. Rodríguez-Valdez, L. M., Villamisar, W., Casales, M., González-Rodríguez, J. G., & others. (2006). Computational simulations of the molecular structure and corrosion properties of amidoethyl, aminoethyl and hydroxyethyl imidazolines inhibitors. Corrosion Science, 48(12), 4053–4064.
Cited by: 248

2. Rodríguez-Valdez, L. M., Martínez-Villafañe, A., & Glossman-Mitnik, D. (2005). Computational simulation of the molecular structure and properties of heterocyclic organic compounds with possible corrosion inhibition properties. Journal of Molecular Structure: THEOCHEM, 713(1), 65–70.
Cited by: 233

3. Glossman-Mitnik, D. (2013). Computational study of the chemical reactivity properties of the Rhodamine B molecule. Procedia Computer Science, 18, 816–825.
Cited by: 131

4. Mendoza-Wilson, A. M., & Glossman-Mitnik, D. (2006). Theoretical study of the molecular properties and chemical reactivity of (+)-catechin and (−)-epicatechin related to their antioxidant ability. Journal of Molecular Structure: THEOCHEM, 761(1), 97–106.
Cited by: 130

5. Gallo, M., Favila, A., & Glossman-Mitnik, D. (2007). DFT studies of functionalized carbon nanotubes and fullerenes as nanovectors for drug delivery of antitubercular compounds. Chemical Physics Letters, 447(1), 105–109.
Cited by: 128

Dr. Daniel Glossman-Mitnik’s work advances global innovation by integrating computational chemistry with materials science and biomedicine, enabling the rational design of sustainable materials and therapeutic compounds. His research bridges theory and application, contributing to cleaner energy technologies, drug discovery, and the broader understanding of molecular behavior for societal and industrial benefit.